Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
AeroVironment, Inc. (NASDAQ: AVAV) shares spiked 10.55 percent to close at $29.76 a share Wednesday. The stock traded between $27.69 and $30.55 on volume of 1.07 million shares traded. The company reported revenues were $64.87 million for the second quarter of fiscal 2014, which topped analysts’ estimates of $55.64 million. Shares of AeroVironment have gained approximately 35.0 percent year-to-date.
Get more information on AeroVironment and free access to the in-depth equity report at:
www.FiveStarEquities.com/AVAV
Bio-Reference Laboratories Inc. (NASDAQ: BRLI) shares dropped 21.68 percent to close at $29.55 a share Wednesday. The stock traded between $29.35 and $34.99 on volume 4.21 million shares traded. The company provided guidance for the fourth quarter of fiscal 2013 that fell short of analysts’ expectations. Shares of Bio-Reference Laboratories have gained approximately 3.0 percent year-to-date.
Get more information on Bio-Reference Laboratories free access to the in-depth equity report at:
www.FiveStarEquities.com/BRLI
CVS Caremark Corporation (NYSE: CVS) shares gained 1.01 percent to close at $66.76 a share Wednesday. The stock traded between $66.22 and $66.96 on volume 4.94 million shares traded. The company announced that it has Coram LLC from Apria Healthcare Group Inc. for approximately $2.1 billion. Shares of CVS Caremark have gained approximately 38.0 percent year-to-date.
Get more information on CVS Caremark and free access to the in-depth equity report at:
www.FiveStarEquities.com/CVS
Frontline Ltd. (NYSE: FRO) shares surged 16.17 percent to close at $2.73 a share Wednesday. The stock traded between $2.47 and $2.74 on volume 3.52 million shares traded. The company reported a net loss of $36.4 million for the third quarter of 2013, compared to a net loss of $120.3 million in the previous quarter. Shares of Frontline have fallen approximately 16.0 percent year-to-date.
Get more information on Frontline and free access to the in-depth equity report at:
www.FiveStarEquities.com/FRO
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
info@fivestarequities.com